Serveur d'exploration SRAS - Curation (Ncbi)

Index « Keywords » - entrée « Cysteine Endopeptidases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cysteine (physiology) < Cysteine Endopeptidases < Cysteine Endopeptidases (administration & dosage)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 35.
[20-40] [0 - 20][0 - 35]
Ident.Authors (with country if any)Title
001575 (2006) Yu-Shan Wu [Taïwan] ; Wen-Hsing Lin ; John T-A Hsu ; Hsing-Pang HsiehAntiviral drug discovery against SARS-CoV.
001669 (2007) S-Q Wang [République populaire de Chine] ; Q-S Du ; K. Zhao ; A-X Li ; D-Q Wei ; K-C ChouVirtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.
001859 (2007) Qi-Shi Du [République populaire de Chine] ; Hao Sun ; Kuo-Chen ChouInhibitor design for SARS coronavirus main protease based on "distorted key theory".
001A41 (2007) Joël VandekerckhovePaper of the Year 2006: award to Pamela Hamill.
001A48 (2007) Yi-Ming Shao [République populaire de Chine] ; Wen-Bin Yang ; Hung-Pin Peng ; Min-Feng Hsu ; Keng-Chang Tsai ; Tun-Hsun Kuo ; Andrew H-J Wang ; Po-Huang Liang ; Chun-Hung Lin ; An-Suei Yang ; Chi-Huey WongStructure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.
001A85 (2008) Chunying Niu [Canada] ; Jiang Yin ; Jianmin Zhang ; John C. Vederas ; Michael N G. JamesMolecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro.
001B62 (2007) Shumei Zhai [République populaire de Chine] ; Wei Liu ; Bing YanRecent patents on treatment of severe acute respiratory syndrome (SARS).
001D60 (2008) Qingang Yang [République populaire de Chine] ; Lili Chen ; Xuchang He ; Zhenting Gao ; Xu Shen ; Donglu BaiDesign and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors.
001D97 (2009) Jeffrey Anderson [États-Unis] ; Celia Schiffer ; Sook-Kyung Lee ; Ronald SwanstromViral protease inhibitors.
001F75 (2009) Arun K. Ghosh [États-Unis] ; Jun Takayama [États-Unis] ; Yoann Aubin [États-Unis] ; Kiira Ratia [États-Unis] ; Rima Chaudhuri [États-Unis] ; Yahira Baez [États-Unis] ; Katrina Sleeman [États-Unis] ; Melissa Coughlin [États-Unis] ; Daniel B. Nichols [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Bellur S. Prabhakar [États-Unis] ; Susan C. Baker [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis]Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease
002144 (2010) R. Ramajayam [Taïwan] ; Kian-Pin Tan ; Hun-Ge Liu ; Po-Huang LiangSynthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease.
002273 (2010) Shengnan Zhang [République populaire de Chine] ; Nan Zhong [République populaire de Chine] ; Fei Xue [République populaire de Chine] ; Xue Kang [République populaire de Chine] ; Xiaobai Ren [République populaire de Chine] ; Jiaxuan Chen [République populaire de Chine] ; Changwen Jin [République populaire de Chine] ; Zhiyong Lou [République populaire de Chine] ; Bin Xia [République populaire de Chine]Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease.
002960 (2014) K B Wong [Hong Kong] ; D C C. Wan [Hong Kong] ; H F Chow [Hong Kong]Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.
002A03 (2015) Kai-Wen Cheng [Taïwan] ; Shu-Chun Cheng [Taïwan] ; Wei-Yi Chen [Taïwan] ; Min-Han Lin [Taïwan] ; Shang-Ju Chuang [Taïwan] ; I-Hsin Cheng [Taïwan] ; Chiao-Yin Sun [Taïwan] ; Chi-Yuan Chou [Taïwan]Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus.
003442 (2020) Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong]Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Cysteine Endopeptidases" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Cysteine Endopeptidases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cysteine Endopeptidases
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021